Philip Brenner

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: GENERAL HOSPITAL PSYCHIATRY. 2024;89:23-31
Association between inflammatory joint disease and severe or treatment-resistant depression: population-based cohort and case-control studies in Sweden
Brenner P; Askling J; Hagg D; Brandt L; Stang P; Reutfors J
Journal article: NEUROSCIENCE APPLIED. 2023;2:102907
Healthcare and psychiatric drug utilization after a suicide attempt in depression: a matched cohort study from Swedish nationwide registers
Johansson V; Brenner P; Karlsson P; Borentain S; Feldman A; Reutfors J
Article: INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE. 2022;26(3):251-258
Health care utilisation in treatment-resistant depression: a Swedish population-based cohort study
Brenner P; Nygren A; Hagg D; Tiger M; O'Hara M; Brandt L; Reutfors J
Journal article: NEUROSCIENCE APPLIED. 2022;1:100228
Trends in hypnotic drug use in depression 2007 – 2017: a Swedish population-based study
Reutfors J; Brandt L; Cabrera P; Karlsson P; Eloranta S; Brenner P
Article: ARCHIVES OF SUICIDE RESEARCH. 2021;25(3):424-438
Risk Factors for Suicide and Suicide Attempts Among Patients With Treatment-Resistant Depression: Nested Case-Control Study
Reutfors J; Andersson TM-L; Tanskanen A; DiBernardo A; Li G; Brandt L; Brenner P
Article: THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY. 2021;11:20451253211006508
Excess deaths in treatment-resistant depression
Brenner P; Reutfors J; Nijs M; Andersson TM-L
Article: BMC PSYCHIATRY. 2020;20(1):232
Risk and risk factors for disability pension among patients with treatment resistant depression- a matched cohort study
Taipale H; Reutfors J; Tanskanen A; Brandt L; Tiihonen J; DiBernardo A; Mittendorfer-Rutz E; Brenner P
Article: ADDICTION. 2020;115(4):768-777
Substance use disorders and risk for treatment resistant depression: a population-based, nested case-control study
Brenner P; Brandt L; Li G; DiBernardo A; Boden R; Reutfors J
Article: DRUG SAFETY. 2020;43(2):135-145
A Post-Authorization Safety Study of Quetiapine as Antidepressant Treatment in Sweden: Nested Case-Control Analyses of Select Outcomes
Reutfors J; Brenner P; Brody B; Wray H; Andersen M; Brandt L
Article: PLOS ONE. 2020;15(7):e0236434
A register-based approach to identifying treatment-resistant depression-Comparison with clinical definitions
Hagg D; Brenner P; Reutfors J; Li G; DiBernardo A; Boden R; Brandt L
Article: BMC RHEUMATOLOGY. 2020;4(1):9
Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
Brenner P; Citarella A; Wingard L; Sundstrom A
Article: NEUROLOGY. 2019;93(24):E2216-E2223
Disability worsening among persons with multiple sclerosis and depression A Swedish cohort study
Binzer S; McKay KA; Brenner P; Hillert J; Manouchehrinia A
Article: ADDICTION. 2019;114(7):1274-1282
Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study
Brenner P; Brandt L; Li G; DiBernardo A; Boden R; Reutfors J
Article: ANNALS OF GENERAL PSYCHIATRY. 2019;18(1):23
All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population
Li G; Fife D; Wang G; Sheehan JJ; Boden R; Brandt L; Brenner P; Reutfors J; DiBernardo A
Article: BMC PSYCHIATRY. 2018;18(1):352
Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study
DiBernardo A; Lin X; Zhang Q; Xiang J; Lu L; Jamieson C; Benson C; Lee K; Boden R; Brandt L; Brenner P; Reutfors J; Li G
Article: JOURNAL OF AFFECTIVE DISORDERS. 2018;238:674-679
Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden
Reutfors J; Andersson TM-L; Brenner P; Brandt L; DiBernardo A; Li G; Hagg D; Wingard L; Boden R
Article: PSYCHONEUROENDOCRINOLOGY. 2018;89:53-58
Depression and fatigue in multiple sclerosis: Relation to exposure to violence and cerebrospinal fluid immunomarkers
Brenner P; Granqvist M; Konigsson J; Al Nimer F; Piehl F; Jokinen J
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2016;23(8):1329-1336
Multiple sclerosis and risk of attempted and completed suicide - a cohort study
Brenner P; Burkill S; Jokinen J; Hillert J; Bahmanyar S; Montgomery S
Article: SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY. 2016;51(7):1047-1054
Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls
Brenner P; Mittendorfer-Rutz E; Jokinen J; Alexanderson K; Hillert J; Tinghog P
Article: BRAIN, BEHAVIOR, AND IMMUNITY. 2016;51:47-55
Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms
Aeinehband S; Brenner P; Stahl S; Bhat M; Fidock MD; Khademi M; Olsson T; Engberg G; Jokinen J; Erhardt S; Piehl F
Article: BMC PSYCHIATRY. 2015;15:286
Is disability pension a risk indicator for future need of psychiatric healthcare or suicidal behavior among MS patients- a nationwide register study in Sweden?
Bjorkenstam C; Tinghog P; Brenner P; Mittendorfer-Rutz E; Hillert J; Jokinen J; Alexanderson K
Journal article: NEUROLOGY. 2015;84(14_supplement)
National Swedish MS Register Based Study: the Symbol Digit Modalities Test as a predictor of work disability (P3.222)
Karrenbauer V; Brenner P; Hillert J; Tinghög P
Article: PLOS ONE. 2014;9(8):e104165
Psychiatric Diagnoses, Medication and Risk for Disability Pension in Multiple Sclerosis Patients; a Population-Based Register Study
Brenner P; Alexanderson K; Bjorkenstam C; Hillert J; Jokinen J; Mittendorfer-Rutz E; Tinghog P
Visa fler

Alla övriga publikationer

Conference publication: EUROPEAN PSYCHIATRY. 2022;65:S111
Association with severe and treatment-resistant depression among patients with inflammatory joint disease. Nationwide nested case-control study in Swedish registers.
Brenner P; Askling J; Stang P; Brandt L; Hagg D; Reutfors J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022;31:368-369
Prescribing patterns for glucagon-like peptide-1 receptor agonists following the introduction of semaglutide in Denmark and Norway
Rasmussen L; Andersen JH; Furu K; Karlstad O; Brenner P; Pottegard A
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021;53:S77
Health care utilization in treatment-resistant depression: a Swedish population based cohort study
Brenner P; Nygren A; Hagg D; Tiger M; O'Hara M; Brandt L; Reutfors J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29:70
Excess deaths associated with treatment resistance in patients with major depressive disorder
Brenner P; Brandt L; Nijs M; Reutfors J; Andersson T
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S48-S49
Risk for disability pension among antidepressant treated patients with and without treatment resistant depression: matched cohort study in Swedish registers
Taipale H; Reutfors J; Tanskanen A; Tiihonen J; Mittendorfer-Rutz E; DiBernardo A; Brandt L; Brenner P
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2019;28:99
Risk factors for suicide and suicide attempts among patients with treatment resistant depression: A population based nested case-control study
Brenner P; Andersson TM-L; Tanskanen A; DiBernardo A; Li G; Brandt L; Reutfors J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27:152
Treatment resistant depression as a risk factor for substance use disorders-A national register-based cohort study
Brenner P; Hagg D; DiBernardo A; Li G; Boden R; Brandt L; Reutfors J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27:153
Substance use disorders are risk factors for treatment resistant depression
Brenner P; Brandt L; Hagg D; Li G; DiBernardo A; Boden R; Reutfors J
Thesis / dissertation: 2017
Psychiatric comorbidity in multiple sclerosis : biological and epidemiological aspects
Brenner, Philip
Review: ACTA NEUROLOGICA SCANDINAVICA. 2016;134:47-54
Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions
Brenner P; Piehl F
Conference publication: EUROPEAN PSYCHIATRY. 2015;30:616
Psychiatric Drug Consumption Among Multiple Sclerosis Patients Before and After Disability Pension; a Controlled Register Study
Brenner P; Mittendorfer-Rutz E; Jokinen J; Alexandersson K; Hillert J; Tinghog P
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:351-352
Cerebrospinal fluid kynurenines in multiple sclerosis: relation to disease course and neurocognitive symptoms
Stahl S; Aeinehband S; Brenner P; Bhat M; Fidock MD; Khademi M; Olsson T; Engberg G; Jokinen J; Erhardt S; Piehl F
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:23-24
Multiple sclerosis and risk of completed and attempted suicide - a national cohort study
Brenner P; Burkill S; Jokinen J; Moore A; Geissbuehler Y; Hillert J; Bahmanyar S; Montgomery S
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2014;20:389
Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study
Brenner P; Jokinen J; Bjorkenstam C; Hillert J; Rutz EM; Alexandersson K; Tinghog P

Anställningar

Adjungerad Adjunkt, Klinisk neurovetenskap, Karolinska Institutet, 2023-2024

Examina och utbildning

Docent, Psykiatri, Karlinska Institutet, 2022
Medicine Doktorsexamen, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2017

Handledare

Silvia Segovia Chacón, Pharmacoepidemiological studies of medication use in reproductive-aged and pregnant women: focus on hypnotics and treatments for migraine, https://ki.se/en/people/silvia-segovia-chacon, 2023

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Handledare

Nyheter från KI

Kalenderhändelser från KI